首页 > 市场调查报告书 > 製药

生物标记

市场调查报告书

商品编码

1741157

数位生物标记市场按数据收集工具、应用、最终用户和地区划分

Digital Biomarkers Market, By Data Collection Tools, By Application, and By End User, and By Geography

出版日期: 2025年03月26日 | 出版商:

Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2025 年数位生物标记市场规模为 51.5 亿美元，到 2032 年将达到 401.6 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 34.1%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	51.5亿美元
效能数据	2020-2024	预测期	2025-2032
预测期：2025-2032年复合年增长率：	34.10%	2032年价值预测	401.6亿美元

数位生物标记是指透过数位装置（包括可携式、穿戴式、植入和胃肠道设备）收集和测量的客观、可量化的生理和行为数据。这些数位设备收集的数据通常用于解释、影响和预测健康相关结果。因此，对数位生物标誌物的需求正在快速增长。

市场动态：

慢性病市场的发展、数位医疗解决方案的日益普及、研发的不断增加、以患者为中心的医疗保健应用的日益普及、智慧型手机使用量的增加、新型可穿戴设备的出现以及治疗应用的不断扩大是预计推动全球数位生物标誌物市场增长的一些关键因素。

例如，2023年2月，Ad Scientiam宣布启动两个雄心勃勃的项目，旨在开发和检验用于重症肌无力(gMG)和视神经脊髓炎频谱障碍(NMOSD)患者自我评估的数位生物标记。这两个项目将利用Ad Scientiam过去五年累积的资产、方法和专业知识，并得到Alexion和阿斯特捷利康罕见疾病部门的支持。

本研究的主要特点

本报告对全球数位生物标记市场进行了详细分析，并以 2024 年为基准年，提供了 2025 年至 2032 年预测期的市场规模和年复合成长率（CAGR%）。
它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
该报告涵盖了全球数位生物标记市场的主要企业概况，基于以下参数，例如公司亮点、产品系列、关键亮点、财务表现和策略。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球数位生物标誌物市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员将透过用于分析全球数位生物标誌物市场的各种策略矩阵来做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 5.15 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	34.10%	2032 Value Projection:	USD 40.16 Bn

Digital biomarkers are defined as objective, quantifiable physiological & behavioral data collected and measured through digital devices such as portables, wearables, implantables, and/or digestible. The data collected by these digital devices is typically used to explain, influence, or predict health-related outcomes. Thus, the demand for digital biomarkers is increasing with a rapid pace.

Market Dynamics:

Growing prevalence of chronic diseases, rising adoption of digital healthcare solutions, increasing research and development, growing adoption of patient-centric healthcare applications, rising use of smartphones, emergence of novel wearables, and expanding therapeutic applications are major factors expected to drive growth of the global digital biomarkers market.

For instance, in February 2023, Ad Scientiam announced the launch of two ambitious programs to develop and validate digital biomarkers for self-assessment of patients suffering from generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorders (NMOSD). The programs will leverage assets, methodologies, and expertise built by Ad Scientiam over the past five years and are supported by Alexion, AstraZeneca Rare Disease.

Key features of the study:

This report provides in-depth analysis of the global digital biomarkers market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global digital biomarkers market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include AliveCor Inc., Altoida Inc., Amgen Inc., Human API, Fitbit, Inc., Biogen Inc, Bayer AG, Akili Interactive Labs, Evidation Health, Inc., GlaxoSmithKline Plc, and Eli Lilly and Company, among others.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global digital biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global digital biomarkers market.

Detailed Segmentation:

Global Digital Biomarkers Market, By Data Collection Tools:
- Wearable Devices
- Implantable Components/Sensors
- Mobile/Tablet Apps
- Platforms
- Desktop Based Software
- Data Integration (Systems that Integrate Data)
Global Digital Biomarkers Market, By Application:
- Sleep and Movement
- Cardiovascular Disease
- Mood and Behavior
- Pain Management
- Neurodegenerative Disorders
- Respiratory Conditions
Global Digital Biomarkers Market, By End User:
- Biopharmaceutical Companies
- Providers
- Payers
Global Digital Biomarkers Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles:
- AliveCor Inc.
- Altoida Inc.
- Amgen Inc.
- Human API
- Fitbit, Inc.
- Biogen Inc.
- Bayer AG
- Akili Interactive Labs
- Evidation Health, Inc.
- GlaxoSmithKline Plc
- Eli Lilly and Company

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Digital Biomarkers, By Data Collection Tools
- Market Digital Biomarkers, By Application
- Market Digital Biomarkers, By End User
- Market Digital Biomarkers, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Increasing adoption of digital healthcare solutions
- High capital investment and data security concerns
- Rapid adoption of health-related mobile applications
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Digital Biomarkers Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Digital Biomarkers Market, By Data Collection Tools, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Wearable Devices
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Implantable Components/Sensors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Mobile/Tablet Apps
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Platforms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Desktop Based Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Data Integration (Systems that Integrate Data)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Digital Biomarkers Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Sleep and Movement
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Cardiovascular Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Mood and Behavior
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Neurodegenerative Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Respiratory Conditions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Digital Biomarkers Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Providers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Payers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Digital Biomarkers Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Data Collection Tools, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)

9. Competitive Landscape

AliveCor Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Altoida Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Human API
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fitbit, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Biogen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bayer AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Akili Interactive Labs
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Evidation Health, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GlaxoSmithKline Plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Analyst Views

10. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

数位生物标记市场按数据收集工具、应用、最终用户和地区划分